Canada
· Delayed Price · Currency is CAD Profound Medical Statistics
Total Valuation
TSX:PRN has a market cap or net worth of CAD 180.24 million. The enterprise value is 120.52 million.
| Market Cap | 180.24M |
| Enterprise Value | 120.52M |
Important Dates
The last earnings date was Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:PRN has 30.04 million shares outstanding. The number of shares has increased by 18.96% in one year.
| Current Share Class | 30.04M |
| Shares Outstanding | 30.04M |
| Shares Change (YoY) | +18.96% |
| Shares Change (QoQ) | +16.57% |
| Owned by Insiders (%) | 7.95% |
| Owned by Institutions (%) | 55.81% |
| Float | 27.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.57 |
| PB Ratio | 2.47 |
| P/TBV Ratio | 2.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.62 |
| EV / Sales | 7.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.31, with a Debt / Equity ratio of 0.10.
| Current Ratio | 11.31 |
| Quick Ratio | 9.90 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -66.13% and return on invested capital (ROIC) is -41.78%.
| Return on Equity (ROE) | -66.13% |
| Return on Assets (ROA) | -38.43% |
| Return on Invested Capital (ROIC) | -41.78% |
| Return on Capital Employed (ROCE) | -65.42% |
| Revenue Per Employee | 120,069 |
| Profits Per Employee | -323,454 |
| Employee Count | 142 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 0.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.15% in the last 52 weeks. The beta is 0.26, so TSX:PRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -40.15% |
| 50-Day Moving Average | 8.02 |
| 200-Day Moving Average | 10.23 |
| Relative Strength Index (RSI) | 38.95 |
| Average Volume (20 Days) | 8,078 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:PRN had revenue of CAD 17.05 million and -45.93 million in losses. Loss per share was -1.75.
| Revenue | 17.05M |
| Gross Profit | 11.53M |
| Operating Income | -52.25M |
| Pretax Income | -45.93M |
| Net Income | -45.93M |
| EBITDA | -51.03M |
| EBIT | -52.25M |
| Loss Per Share | -1.75 |
Balance Sheet
The company has 66.74 million in cash and 7.02 million in debt, giving a net cash position of 59.72 million or 1.99 per share.
| Cash & Cash Equivalents | 66.74M |
| Total Debt | 7.02M |
| Net Cash | 59.72M |
| Net Cash Per Share | 1.99 |
| Equity (Book Value) | 73.00M |
| Book Value Per Share | 2.43 |
| Working Capital | 78.50M |
Cash Flow
| Operating Cash Flow | -39.11M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 67.64%, with operating and profit margins of -306.45% and -269.39%.
| Gross Margin | 67.64% |
| Operating Margin | -306.45% |
| Pretax Margin | -269.40% |
| Profit Margin | -269.39% |
| EBITDA Margin | -299.29% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:PRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.96% |
| Shareholder Yield | -18.96% |
| Earnings Yield | -25.48% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on October 16, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 16, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |